Earnings Feed
Start Free
Century Therapeutics, Inc.·4

Jun 15, 7:56 PM ET

Carr Douglas 4

Research Summary

AI-generated summary

Updated

Century Therapeutics (IPSC) SVP Finance Douglas Carr Sells 1,654 Shares

What Happened
Douglas Carr, SVP Finance & Operations at Century Therapeutics (IPSC), disposed of 1,654 shares on 2026-06-12 at $2.23 per share, generating proceeds of $3,692. The sale is reported as a disposition (code S) and was done to satisfy tax withholding obligations related to the vesting of restricted stock units.

Key Details

  • Transaction date: 2026-06-12; Form 4 filed: 2026-06-15.
  • Type: Sale (S) — 1,654 shares at $2.23 per share; total proceeds $3,692.
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnote: F1 — sale was automatic to cover tax withholding for RSU vesting and not at the reporting person's discretion.
  • No 10b5-1 plan or other special trading program is indicated in the filing excerpt.

Context
Sales made solely to cover tax withholding on vested awards are routine and are generally not considered a strong directional signal about an insider’s view of the company, especially given the small dollar value here (~$3.7k). Retail investors typically weigh purchases more heavily than such routine, administrative sales.